Swiss Respiratory Biotech Windward Up 7.9% in US Trading Debut
Windward Bio Group AG shares rose 7.9% in its trading debut, after the company raised about $225 million in an initial public offering and private placement.
We haven't written up this one. Bloomberg has the full story — the link below goes straight to it.